A decision to reclassify marijuana as a Schedule III drug would completely change how the industry pays for it, how we think of weed, and what we can learn about it. The U.S Drug Enforcement ...
CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...
Cannabis may be on its way to being less restricted in the U.S. after a recent recommendation from the Health and Human Services Department to reschedule the drug's classification. Last week, the HHS ...
A view of a marijuana plant in San Anselmo, California, on August 11, 2025. Reporter President Donald Trump has ordered federal restrictions on marijuana to be loosened. The executive order, signed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results